# Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes

> **NCT03654937** · PHASE4 · COMPLETED · sponsor: **Universität des Saarlandes** · enrollment: 45 (actual)

## Conditions studied

- Influenza Virus Vaccine Adverse Reaction
- Influenza Vaccine Allergy

## Interventions

- **BIOLOGICAL:** Influenza Vaccination

## Key facts

- **NCT ID:** NCT03654937
- **Lead sponsor:** Universität des Saarlandes
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2018-04-01
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2018-08-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03654937

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03654937, "Immune Response and Risk of Side Effects After Influenza Vaccination in Athletes". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT03654937. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*